FDA approves novel preventive treatment for migraine - FDA Press Releases

FDA approves Aimovig for the preventive treatment of migraine. Aimovig works by blocking the activity of a molecule that is involved in migraine attacks.

from Food and Drug Administration--Press Releases https://ift.tt/2rQdJhP
via IFTTT